Dispersyn Gerrit
SEC CIK 1704417 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PHIO | Phio Pharmaceuticals Corp. | Pres, CEO, Dir | 212.3K | $9,780 | — | 3 | 2021-08-16 | 2022-03-01 |
Transactions 3
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-03 | 2022-03-01 | PHIO | Phio Pharmaceuticals Corp. | Dispersyn Gerrit | Pres, CEO, Dir | F - Tax | $0.82 | -8,954 | 212.3K | -4% | -$7,342 | |
| 2022-02-16 | 2022-02-15 | PHIO | Phio Pharmaceuticals Corp. | Dispersyn Gerrit | Pres, CEO, Dir | A - Grant | $0.00 | +126.0K | 221.3K | +132% | $0 | |
| 2021-08-17 | 2021-08-16 | PHIO | Phio Pharmaceuticals Corp. | Dispersyn Gerrit | Pres, CEO, Dir | P - Purchase | $1.63 | +6,000 | 95.3K | +7% | +$9,780 |